Cross-neutralization of influenza A viruses mediated by a single antibody loop
about
Dynamic Viral Glycoprotein Machines: Approaches for Probing Transient States That Drive Membrane FusionInfluenza Vaccination Strategies: Comparing Inactivated and Live Attenuated Influenza VaccinesDeveloping Universal Influenza Vaccines: Hitting the Nail, Not Just on the HeadStructural characterization of viral epitopes recognized by broadly cross-reactive antibodiesUniversal immunity to influenza must outwit immune evasionMechanisms of hemagglutinin targeted influenza virus neutralizationHeterosubtypic antibody recognition of the influenza virus hemagglutinin receptor binding site enhanced by avidityInfluenza Human Monoclonal Antibody 1F1 Interacts with Three Major Antigenic Sites and Residues Mediating Human Receptor Specificity in H1N1 VirusesA recurring motif for antibody recognition of the receptor-binding site of influenza hemagglutininStructure of a Classical Broadly Neutralizing Stem Antibody in Complex with a Pandemic H2 Influenza Virus HemagglutininStructure of RSV Fusion Glycoprotein Trimer Bound to a Prefusion-Specific Neutralizing AntibodyBroadly Neutralizing Antibody PGT121 Allosterically Modulates CD4 Binding via Recognition of the HIV-1 gp120 V3 Base and Multiple Surrounding GlycansHuman antibodies that neutralize respiratory droplet transmissible H5N1 influenza virusesAntibody Recognition of the Pandemic H1N1 Influenza Virus Hemagglutinin Receptor Binding SiteThe Effects of Somatic Hypermutation on Neutralization and Binding in the PGT121 Family of Broadly Neutralizing HIV AntibodiesA common solution to group 2 influenza virus neutralizationRole of κ→λ light-chain constant-domain switch in the structure and functionality of A17 reactibodyReceptor mimicry by antibody F045–092 facilitates universal binding to the H3 subtype of influenza virusAlternative Recognition of the Conserved Stem Epitope in Influenza A Virus Hemagglutinin by a VH3-30-Encoded Heterosubtypic AntibodyConserved Neutralizing Epitope at Globular Head of Hemagglutinin in H3N2 Influenza VirusesTwo Escape Mechanisms of Influenza A Virus to a Broadly Neutralizing Stalk-Binding AntibodyAnti-Hemagglutinin Antibody Derived Lead Peptides for Inhibitors of Influenza Virus BindingModified vaccinia virus ankara (MVA) as production platform for vaccines against influenza and other viral respiratory diseasesInfluenza hemagglutinin stem-fragment immunogen elicits broadly neutralizing antibodies and confers heterologous protectionLarge-scale analysis of B-cell epitopes on influenza virus hemagglutinin - implications for cross-reactivity of neutralizing antibodies.The kinase mTOR modulates the antibody response to provide cross-protective immunity to lethal infection with influenza virus.Extreme evolutionary conservation of functionally important regions in H1N1 influenza proteome.Vaccination of monoglycosylated hemagglutinin induces cross-strain protection against influenza virus infections.Diversity of the murine antibody response targeting influenza A(H1N1pdm09) hemagglutininIn silico structural homology modelling and docking for assessment of pandemic potential of a novel H7N9 influenza virus and its ability to be neutralized by existing anti-hemagglutinin antibodies.The breadth of cross sub-type neutralisation activity of a single domain antibody to influenza hemagglutinin can be increased by antibody valency.Influenza vaccines: a moving interdisciplinary field.An anti-H5N1 influenza virus FcDART antibody is a highly efficacious therapeutic agent and prophylactic against H5N1 influenza virus infectionPreexisting human antibodies neutralize recently emerged H7N9 influenza strains.Prospects for antibody-based universal influenza vaccines in the context of widespread pre-existing immunity.Serum Samples From Middle-aged Adults Vaccinated Annually with Seasonal Influenza Vaccines Cross-neutralize Some Potential Pandemic Influenza Viruses.The Analysis of B-Cell Epitopes of Influenza Virus Hemagglutinin.Glycosylation changes in the globular head of H3N2 influenza hemagglutinin modulate receptor binding without affecting virus virulenceInfluenza immunization elicits antibodies specific for an egg-adapted vaccine strainStructural basis of influenza virus fusion inhibition by the antiviral drug Arbidol.
P2860
Q26772129-FDB3CE1A-0387-4C6D-BB08-4BA3BA248D40Q26783844-165B5A99-38E6-4A4B-9C95-A68876077525Q26783897-5E996F72-972A-492D-9864-36AB7005D4AEQ26823492-9F925850-E254-4359-A6DB-4DECFB8A5915Q26991896-435F5534-5AE1-4314-813D-F80B6009C6F6Q27302234-8DEA3381-E15D-42AE-9B63-1D8A73F2AD8BQ27673861-685051EC-076C-4A7E-9100-ECCBDCB2D84BQ27675477-FC49438E-C712-44FF-9795-E940984D6AD8Q27676298-305F04DD-A2E9-4891-B8D1-0F6CD01ADEBCQ27677191-131801F0-F32A-4AE4-8C85-55B89C3029C5Q27677570-56253779-0556-4DDF-BCEF-0BCFD62B3CACQ27678062-2FE0F27F-56C3-43DD-A398-683C3B793709Q27679859-37CA014E-DA0F-4264-92FD-809B7753E05FQ27679927-ECD4FCAC-7632-42FD-9A80-3A7E150933CDQ27680688-11DDDF73-2ED7-4166-91C1-FCB66D960754Q27680873-EEA7A661-A469-4217-9D0B-1EB1B392ED66Q27681993-8FA1D328-F698-47B2-B3EC-54141E9E5E56Q27683156-88487424-695D-4BFF-97DF-5F7B67C120C7Q27683187-0074F203-6D13-4F7A-B971-CA8C9A7F37BDQ27683198-6182E239-CB5A-4807-9C74-E5C4546BB0A8Q28552195-9699D438-8165-4AE3-869F-E6742D49FBABQ28552622-126831E0-911C-488F-AA9E-3E724C03EE8FQ30209342-E1F30600-46B3-403D-84CD-C25CA3ED7B7BQ30209769-526AD546-5B8E-441E-B4D6-DCA15BD6A4D0Q30217235-1C3BFF52-6145-46B3-90D9-C86F5141BFD9Q30354732-E556DB7E-5887-442D-B87F-CF3AE710C640Q30356104-D52EA280-FB12-4F3A-A037-CBE89EA18411Q30358388-A95B09F2-0C38-4C05-ACF8-E34242804654Q30363595-A313149E-78CD-4645-BE70-56C205AE9B9AQ30364943-D23F61C5-FDA0-4ECC-B8C6-4A446037AF0BQ30365366-CAB12C9D-A12A-46DA-9821-5F05A28C78EBQ30367695-DFAB96D6-8FAC-4FC4-A463-D386E86724B4Q30371674-3E158211-D1C5-40B7-9D72-877D7965DF86Q30371836-9ECBCB2F-1A79-4136-AA51-553C54FB808EQ30376724-371B6934-1381-43E7-A7AA-6C948F8D76E5Q30377531-514EF50B-2F7B-4B13-A51A-11A74F44621EQ30387177-0EEB1298-4FFA-416F-B70E-AB530C5E1A9DQ30394678-61E5DFB8-C7BF-4486-AFA1-AF2837FBD8C1Q30395005-8398CD3A-DDFC-4CE4-B917-71DB87FD0DBEQ30396717-08F5854A-7DAA-4309-98B8-7263182857C6
P2860
Cross-neutralization of influenza A viruses mediated by a single antibody loop
description
2012 nî lūn-bûn
@nan
2012 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած
@hyw
2012 թվականի սեպտեմբերին հրատարակված գիտական հոդված
@hy
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
name
Cross-neutralization of influenza A viruses mediated by a single antibody loop
@ast
Cross-neutralization of influenza A viruses mediated by a single antibody loop
@en
Cross-neutralization of influenza A viruses mediated by a single antibody loop
@nl
type
label
Cross-neutralization of influenza A viruses mediated by a single antibody loop
@ast
Cross-neutralization of influenza A viruses mediated by a single antibody loop
@en
Cross-neutralization of influenza A viruses mediated by a single antibody loop
@nl
prefLabel
Cross-neutralization of influenza A viruses mediated by a single antibody loop
@ast
Cross-neutralization of influenza A viruses mediated by a single antibody loop
@en
Cross-neutralization of influenza A viruses mediated by a single antibody loop
@nl
P2093
P2860
P50
P3181
P356
P1433
P1476
Cross-neutralization of influenza A viruses mediated by a single antibody loop
@en
P2093
Adam Rubrum
Aleksandr M Faynboym
Andrew B Ward
Arun K Kashyap
John Steel
Lawrence Horowitz
Michael A Dillon
Michael Horowitz
Ramesh R Bhatt
Reza Khayat
P2860
P2888
P304
P3181
P356
10.1038/NATURE11414
P407
P577
2012-09-27T00:00:00Z
P6179
1015902165